Expression of smoothmuscle cellmarkers and co-activators in calcified aortic valves

European Heart Journal

Volumn 36, Issue 21, 2015, Pages 1335-1345

  Latif, Najma ^a,b   Sarathchandra, Padmini ^a   Chester, Adrian H ^a,b   Yacoub, Magdi H ^a,b  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b QATAR CARDIOVASCULAR RESEARCH CENTER   (Qatar)

Author keywords

Calcification; Cardiac; Human; Smooth muscle cells; Valve

Indexed keywords

CELL PROTEIN; DESMIN; MYOCARDIN; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; MYOCARDIN RELATED TRANSCRIPTION FACTOR B; SMOOTH MUSCLE CELL MARKER; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; CALPONIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ADOLESCENT; ADULT; AORTA STENOSIS; ARTERY CALCIFICATION; ARTICLE; BASEMENT MEMBRANE; CALCIFIC AORTIC STENOSIS; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSE BODY; ENDOTHELIUM CELL; FEMALE; FOAM CELL; FOCAL ADHESION; GOLGI COMPLEX; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROVASCULATURE; MOLECULAR PATHOLOGY; MYOFIBROBLAST; MYOFILAMENT; PHENOTYPE; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROUGH ENDOPLASMIC RETICULUM; SMOOTH MUSCLE FIBER; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; AORTA VALVE; AORTA VALVE STENOSIS; CALCINOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE; YOUNG ADULT;

ADOLESCENT; ADULT; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOMARKERS; CALCINOSIS; CALCIUM-BINDING PROTEINS; FEMALE; FOAM CELLS; HUMANS; MALE; MICROFILAMENT PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NUCLEAR PROTEINS; PHENOTYPE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; YOUNG ADULT;

EID: 84938097016     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht547     Document Type: Article

References (48)

1. Ramaraj R, Sorrell VL. Degenerative aortic stenosis. BMJ 2008;336:550-555.
2. Bosse Y, Mathieu P, Pibarot P. Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. J Am Coll Cardiol 2008;51:1327-1336.
3. RosamondW, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y, American Heart Association Statistics C, Stroke Statistics S. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
4. Rajamannan NM. Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler Thromb Vasc Biol 2009;29:162-168.
5. Xu S, Liu AC, Gotlieb AI. Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta. Cardiovasc Pathol 2010;19:236-247.
6. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-3326.
7. Markwald RR, Fitzharris TP, Manasek FJ. Structural development of endocardial cushions. Am J Anat 1977;148:85-119.
8. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006;113:1344-1352.
9. Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, Bischoff J. Human pulmonary valve progenitor cells exhibit endothelial/ mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res 2006;99:861-869.
10. Visconti RP, Ebihara Y, LaRue AC, Fleming PA, McQuinn TC, Masuya M, Minamiguchi H, Markwald RR, OgawaM, Drake CJ. An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circ Res 2006;98:690-696.
11. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007;27:1248-1258.
12. Bairati A, DeBiasi S. Presence of a smooth muscle system in aortic valve leaflets. Anat Embryol (Berl) 1981;161:329-340.
13. Cimini M, Rogers KA, BoughnerDR. Smoothelin-positive cells in human and porcine semilunar valves. Histochem Cell Biol 2003;120:307-317.
14. Della Rocca F, Sartore S, Guidolin D, Bertiplaglia B, Gerosa G, Casarotto D, Pauletto P. Cell composition of the human pulmonary valve: a comparative study with the aortic valve-the VESALIO Project. Vitalitate Exornatum Succedaneum Aorticum labore Ingegnoso Obtinebitur. Ann Thorac Surg 2000;70:1594-1600.
15. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomechem 2010; 43:146-155.
16. Mahoney WM, Schwartz SM. Defining smooth muscle cells and smooth muscle injury. J Clin Invest 2005;115:221-224.
17. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995;75:487-517.
18. Fukuda D, AikawaM. Intimal smooth muscle cells: the context-dependent origin. Circulation 2010;122:2005-2008.
19. IyemereVP, Proudfoot D,Weissberg PL, ShanahanCM. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 2006; 260:192-210.
20. Gomez D, Owens GK. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 2012;95:156-164.
21. Bertipaglia B, Ortolani F, Petrelli L, Gerosa G, Spina M, Pauletto P, Casarotto D, Marchini M, Sartore S, Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur Project. Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur). Ann Thorac Surg 2003;75:1274-1282.
22. Messier RH Jr, Bass BL, Aly HM, Jones JL, DomkowskiPW,Wallace RB, Hopkins RA. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J Surg Res 1994;57:1-21.
23. Rajamannan NM, Nealis TB, Subramaniam M, Pandya S, Stock SR, Ignatiev CI, Sebo TJ, Rosengart TK, EdwardsWD,McCarthy PM, BonowRO, Spelsberg TC. Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. Circulation 2005; 111:3296-3301.
24. Speer MY, Yang HY, Brabb T, Leaf E, Look A, Lin WL, Frutkin A, Dichek D, Giachelli CM. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009;104:733-741.
25. Naik V, Leaf EM, Hu JH, Yang HY, Nguyen NB, Giachelli CM, Speer MY. Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res 2012;94:545-554.
26. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214-220.
27. Yoshida T, Sinha S, Dandre F,Wamhoff BR, Hoofnagle MH, Kremer BE,Wang DZ, Olson EN, Owens GK. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 2003;92:856-864.
28. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003;35:577-593.
29. Paranya G, Vineberg S, Dvorin E, Kaushal S, Roth SJ, Rabkin E, Schoen FJ, Bischoff J. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am J Pathol 2001;159:1335-1343.
30. Krenning G, Moonen JR, van Luyn MJ, Harmsen MC. Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials 2008;29:3703-3711.
31. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002;90:1189-1196.
32. Cevallos M, Riha GM,Wang X, Yang H, Yan S, Li M, Chai H, Yao Q, Chen C. Cyclic strain induces expression of specific smooth muscle cell markers in human endothelial cells. Differentiation 2006;74:552-561.
33. Balachandran K, Alford PW, Wylie-Sears J, Goss JA, Grosberg A, Bischoff J, Aikawa E, Levine RA, Parker KK. Cyclic strain induces dual-mode endothelialmesenchymal transformation of the cardiac valve. Proc Natl Acad Sci USA 2011; 108:19943-19948.
34. Wylie-Sears J, Aikawa E, Levine RA, Yang JH, Bischoff J. Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler Thromb Vasc Biol 2011;31: 598-607.
35. Chen JH, Chen WL, Sider KL, Yip CY, Simmons CA. Beta-catenin mediates mechanically regulated, transforming growth factor-beta1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol 2011;31: 590-597.
36. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004;95:253-260.
37. Kim L, Kim do K, Yang WI, Shin DH, Jung IM, Park HK, Chang BC. Overexpression of transforming growth factor-beta 1 in the valvular fibrosis of chronic rheumatic heart disease. J Korean Med Sci 2008;23:41-48.
38. Jian B, Narula N, Li QY, Mohler ER 3rd, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003;75:457-465; discussion 465-466.
39. Clark-Greuel JN, Connolly JM, Sorichillo E, Narula NR, Rapoport HS, Mohler ER3rd, Gorman JH 3rd, Gorman RC, Levy RJ. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg 2007;83:946-953.
40. Cushing MC, Liao JT, Anseth KS. Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules. Matrix Biol 2005;24:428-437.
41. Crider BJ, RisingerGMJr, Haaksma CJ, Howard EW, Tomasek JJ. Myocardin-related transcription factors A and B are key regulators of TGF-beta1-induced fibroblast to myofibroblast differentiation. J Invest Dermatol 2011;131:2378-2385.
42. Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003;113:329-342.
43. Shetty R, Pibarot P, Audet A, Janvier R, Dagenais F, Perron J, Couture C, Voisine P, Despres JP, Mathieu P. Lipid-mediated inflammation and degeneration of bioprosthetic heart valves. Eur J Clin Invest 2009;39:471-480.
44. BottioT, Thiene G, Pettenazzo E, Ius P, Bortolotti U, Rizzoli G, ValfreC, Casarotto D, Valente M. Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants. J Thorac Cardiovasc Surg 2003;126:99-105.
45. Yamada T, Satoh S, Sueyoshi S, Mitsumata M, Matsumoto T, Ueno T, Uehara K, Mizutani T. Ubiquitin-positive foam cells are identified in the aortic and mitral valves with atherosclerotic involvement. J Atheroscler Thromb 2009;16:472-479.
46. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 1999; 277:C1-C9.
47. Cheung C, Bernardo AS, TrotterMW, Pedersen RA, Sinha S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat Biotechnol 2012;30:165-173.
48. Bertazzo S, Gentleman E, Cloyd KL, Chester AH, Yacoub MH, Stevens MM. Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater 2013;12:576-583.